These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6628659)

  • 1. [Effect of aggregating agents on the pentosephosphate pathway of carbohydrate metabolism in human blood platelet extracts].
    Makarov SA; Kudriavtseva GV; Kolotilova AI
    Farmakol Toksikol; 1983; 46(5):48-52. PubMed ID: 6628659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by fructose 1,6-bisphosphate of transaldolase from Escherichia coli.
    Ogawa T; Murakami K; Yoshino M
    FEMS Microbiol Lett; 2016 Sep; 363(17):. PubMed ID: 27481705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of aggregation inducers and inhibitors on the pentosephosphate pathway enzymes of glucose conversion in the thrombocytes].
    Nikulin AA; Aksenova VM; Petrovich IuA
    Farmakol Toksikol; 1979; 42(3):254-7. PubMed ID: 221244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro.
    Haaland HD; Holmsen H
    Platelets; 2011; 22(5):328-37. PubMed ID: 21388249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of 5-methyl-4-hydroxy-3[2H]-furanone in cytosolic extracts obtained from Zygosaccharomyces rouxii.
    Hauck T; Landmann C; Brühlmann F; Schwab W
    J Agric Food Chem; 2003 Feb; 51(5):1410-4. PubMed ID: 12590490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of thrombin and prostaglandins E and F on various indices of carbohydrate metabolism in human platelets].
    Makarov SA; Kudriavtseva GV; Kolotilova AI
    Vopr Med Khim; 1985; 31(5):68-71. PubMed ID: 3867194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of disorders of pentosephosphate pathway of glucose oxidation in the pathogenesis of the arrest of fetal development in miscarriage].
    Kuznetsova VA; Slobodin VB; Moreva IV; Sitnikova OG
    Akush Ginekol (Mosk); 1989 Jun; (6):36-8. PubMed ID: 2774076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of various substances which induce and inhibit aggregation on the uptake of deoxyglucose by human blood platelets.
    Gaut ZN
    J Pharmacol Exp Ther; 1974 Jul; 190(1):180-6. PubMed ID: 4367897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of series E and F prostaglandins on the reaction of the pentosephosphate pathway of carbohydrate metabolism in isolated perfused rat organs].
    Kudriavtseva GV; Makarov SA; Sekretareva EV
    Biokhimiia; 1984 Nov; 49(11):1847-53. PubMed ID: 6596960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentose phosphate pathway flux analysis for glycopeptide antibiotic vancomycin production during glucose-limited cultivation of Amycolatopsis orientalis.
    Ayar-Kayali H
    Prep Biochem Biotechnol; 2011; 41(1):94-105. PubMed ID: 21229467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the oxidative pentose phosphate pathway in thiamine biosynthesis in Salmonella typhimurium.
    Enos-Berlage JL; Downs DM
    J Bacteriol; 1996 Mar; 178(5):1476-9. PubMed ID: 8631729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of glucose oxidation to aggregation of human platelets.
    Chaudhry AA; Sagone AL; Metz EN; Balcerzak SP
    Blood; 1973 Feb; 41(2):249-58. PubMed ID: 4707615
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructure of the platelet release reaction in response to various aggregating agents and their inhibitors.
    Droller MJ
    Lab Invest; 1973 Dec; 29(6):595-606. PubMed ID: 4763720
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid oxidation by human platelets and its stimulation by thrombin.
    Donabedian R; Nemerson Y
    Am J Physiol; 1971 Nov; 221(5):1283-6. PubMed ID: 5124271
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "New" platelet diseases and their biochemical aspects.
    De Gaetano G
    Acta Vitaminol Enzymol; 1973; 27(5):223-32. PubMed ID: 4596641
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose-6-phosphate dehydrogenase activity in human platelets and its secretion.
    Yardimci TU; Ulutin ON
    New Istanbul Contrib Clin Sci; 1976 Dec; 11(3):142-7. PubMed ID: 1028029
    [No Abstract]   [Full Text] [Related]  

  • 20. The phosphogluconate pathway and synthesis of 5-phosphoribosyl-1-pyrophosphate in human fibroblasts.
    Raivio KO; Lazar CS; Krumholz HR; Becker MA
    Biochim Biophys Acta; 1981 Nov; 678(1):51-7. PubMed ID: 6171305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.